|
Volumn 53, Issue 4, 1997, Pages 681-699
|
Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
GROWTH HORMONE;
HYPOTHALAMUS RELEASE INHIBITING FACTOR;
OCTREOTIDE;
ABDOMINAL PAIN;
ACROMEGALY;
ADENOHYPOPHYSIS;
ALOPECIA;
ANEMIA;
CHOLELITHIASIS;
CLINICAL TRIAL;
CONSTIPATION;
DIARRHEA;
DRUG BLOOD LEVEL;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
ERYTHEMA;
FLATULENCE;
GASTROINTESTINAL TRACT;
GROWTH HORMONE BLOOD LEVEL;
HUMAN;
HYPERGLYCEMIA;
HYPOGLYCEMIA;
HYPOPHYSIS FUNCTION;
INJECTION PAIN;
INTRAMUSCULAR DRUG ADMINISTRATION;
META ANALYSIS;
NAUSEA;
QUALITY OF LIFE;
REVIEW;
STEATORRHEA;
SUBCUTANEOUS DRUG ADMINISTRATION;
SUSTAINED RELEASE PREPARATION;
SYMPTOM;
VOMITING;
|
EID: 0030911816
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-199753040-00009 Document Type: Review |
Times cited : (111)
|
References (71)
|